## Abstract Aliphatic polyesters are believed to be good biocompatible polymers for tissue engineering because of their biodegradability and nontoxicity of the degradated products. However, it is necessary to reduce the nonspecific protein adsorption for the application of biodegradable polymers to
Enhancing blood compatibility of biodegradable polymers by introducing sulfobetaine
β Scribed by Jun Cao; Yuan-Wei Chen; Xin Wang; Xiang-Lin Luo
- Book ID
- 102873740
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 752 KB
- Volume
- 97A
- Category
- Article
- ISSN
- 1549-3296
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Novel biodegradable polycaprolactone containing N,Nβ²βbis (2βhydroxyethyl) methylamine ammonium propane sulfonate (PCLβAPS) was synthesized by ringβopening polymerization. The resulting polymers were characterized by nuclear magnetic resonance spectrum (NMR), Fourier transform infrared (FTIR) spectroscopy, gel permeation chromatograph (GPC), differential scanning calorimetry (DSC), and water contact angle (WCA). These measurements showed that the APS unit was introduced into polymers. The hydrolysis of PCLβAPS was evaluated by soaking the polymer membranes in a pH = 3.20 acid solution. The rate of weight loss was increased with the content of APS increasing in polymer. The compatibility of polymers were evaluated by platelet adhesion, hemolytic test, and activated partial thromboplastic time (APTT) and prothrombin time (PT) experiments. Results showed that adhered platelets deceased after introducing sulfobetaine as compared to the control PCL, little hemolysis took place on PCLβAPS, and APTT of PCLβAPS polymers was prolonged than that of control PCL. Therefore, polycaprolactone containing sulfobetaine is a promising biodegradable polymer with good blood compatibility. Β© 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A:, 2011.
π SIMILAR VOLUMES
The activation of the complement system by polymer materials and their blood compatibility. One of the negative effects of the clinical application of various bloodcontaining biomedical devices is the activation of the complement system induced by a foreign surface. A method of determining the hemol